Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients
Status:
Recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of DAC combined with HAAG
regimen in the induction treatment of newly diagnosed AML patients younger than 60 years.
Phase:
Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University
Collaborators:
Changzhou No.2 People's Hospital Huai'an Second People's Hospital Jingjiang People's Hospital Second Affiliated Hospital of Soochow University The First People's Hospital of Lianyungang The Third People's Hospital of Kunshan Zhangjiagang First People's Hospital